130 related articles for article (PubMed ID: 11822927)
1. Levothyroxine treatment and occurrence of fracture of the hip.
Sheppard MC; Holder R; Franklyn JA
Arch Intern Med; 2002 Feb; 162(3):338-43. PubMed ID: 11822927
[TBL] [Abstract][Full Text] [Related]
2. J-Shaped Association Between Postoperative Levothyroxine Dosage and Fracture Risk in Thyroid Cancer Patients: A Retrospective Cohort Study.
Shin DW; Suh B; Lim H; Yun JM; Song SO; Park Y
J Bone Miner Res; 2018 Jun; 33(6):1037-1043. PubMed ID: 29447437
[TBL] [Abstract][Full Text] [Related]
3. Derivation and validation of updated QFracture algorithm to predict risk of osteoporotic fracture in primary care in the United Kingdom: prospective open cohort study.
Hippisley-Cox J; Coupland C
BMJ; 2012 May; 344():e3427. PubMed ID: 22619194
[TBL] [Abstract][Full Text] [Related]
4. Risk of hip/femur fracture after stroke: a population-based case-control study.
Pouwels S; Lalmohamed A; Leufkens B; de Boer A; Cooper C; van Staa T; de Vries F
Stroke; 2009 Oct; 40(10):3281-5. PubMed ID: 19661475
[TBL] [Abstract][Full Text] [Related]
5. Levothyroxine dose and risk of fractures in older adults: nested case-control study.
Turner MR; Camacho X; Fischer HD; Austin PC; Anderson GM; Rochon PA; Lipscombe LL
BMJ; 2011 Apr; 342():d2238. PubMed ID: 21527461
[TBL] [Abstract][Full Text] [Related]
6. Long-term proton pump inhibitor therapy and risk of hip fracture.
Yang YX; Lewis JD; Epstein S; Metz DC
JAMA; 2006 Dec; 296(24):2947-53. PubMed ID: 17190895
[TBL] [Abstract][Full Text] [Related]
7. Risk of cancer in long-term levothyroxine users: Retrospective population-based study.
Wu CC; Islam MM; Nguyen PA; Poly TN; Wang CH; Iqbal U; Li YJ; Yang HC
Cancer Sci; 2021 Jun; 112(6):2533-2541. PubMed ID: 33793038
[TBL] [Abstract][Full Text] [Related]
8. Use of beta-blockers and the risk of hip/femur fracture in the United Kingdom and The Netherlands.
de Vries F; Souverein PC; Cooper C; Leufkens HG; van Staa TP
Calcif Tissue Int; 2007 Feb; 80(2):69-75. PubMed ID: 17308987
[TBL] [Abstract][Full Text] [Related]
9. Levothyroxine use and the risk of breast cancer: a nation-wide population-based case-control study.
Wu CC; Yu YY; Yang HC; Nguyen PA; Poly TN; Islam MM; Iqbal U; Khan HAA; Wang YC; Cheng YT; Li YC; Jian WS
Arch Gynecol Obstet; 2018 Aug; 298(2):389-396. PubMed ID: 29961136
[TBL] [Abstract][Full Text] [Related]
10. Predicting the 10-year risk of hip and major osteoporotic fracture in rheumatoid arthritis and in the general population: an independent validation and update of UK FRAX without bone mineral density.
Klop C; de Vries F; Bijlsma JW; Leufkens HG; Welsing PM
Ann Rheum Dis; 2016 Dec; 75(12):2095-2100. PubMed ID: 26984006
[TBL] [Abstract][Full Text] [Related]
11. Falling threshold for treatment of borderline elevated thyrotropin levels-balancing benefits and risks: evidence from a large community-based study.
Taylor PN; Iqbal A; Minassian C; Sayers A; Draman MS; Greenwood R; Hamilton W; Okosieme O; Panicker V; Thomas SL; Dayan C
JAMA Intern Med; 2014 Jan; 174(1):32-9. PubMed ID: 24100714
[TBL] [Abstract][Full Text] [Related]
12. A population-based case-control study: proton pump inhibition and risk of hip fracture by use of bisphosphonate.
Lee J; Youn K; Choi NK; Lee JH; Kang D; Song HJ; Park BJ
J Gastroenterol; 2013 Sep; 48(9):1016-22. PubMed ID: 23307040
[TBL] [Abstract][Full Text] [Related]
13. Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients.
Corley DA; Kubo A; Zhao W; Quesenberry C
Gastroenterology; 2010 Jul; 139(1):93-101. PubMed ID: 20353792
[TBL] [Abstract][Full Text] [Related]
14. Risk analysis for second hip fracture in patients after hip fracture surgery: a nationwide population-based study.
Shen SH; Huang KC; Tsai YH; Yang TY; Lee MS; Ueng SW; Hsu RW
J Am Med Dir Assoc; 2014 Oct; 15(10):725-31. PubMed ID: 25017390
[TBL] [Abstract][Full Text] [Related]
15. Use of alpha-blockers and the risk of hip/femur fractures.
Souverein PC; Van Staa TP; Egberts AC; De la Rosette JJ; Cooper C; Leufkens HG
J Intern Med; 2003 Dec; 254(6):548-54. PubMed ID: 14641795
[TBL] [Abstract][Full Text] [Related]
16. Exposure to antiepileptic drugs and the risk of hip fracture: a case-control study.
Tsiropoulos I; Andersen M; Nymark T; Lauritsen J; Gaist D; Hallas J
Epilepsia; 2008 Dec; 49(12):2092-9. PubMed ID: 18479399
[TBL] [Abstract][Full Text] [Related]
17. Inhaled and nasal corticosteroid use and the risk of fracture.
Suissa S; Baltzan M; Kremer R; Ernst P
Am J Respir Crit Care Med; 2004 Jan; 169(1):83-8. PubMed ID: 14551165
[TBL] [Abstract][Full Text] [Related]
18. Cigarette smoking, alcohol consumption, and risk of hip fracture in women.
Baron JA; Farahmand BY; Weiderpass E; Michaëlsson K; Alberts A; Persson I; Ljunghall S
Arch Intern Med; 2001 Apr; 161(7):983-8. PubMed ID: 11295961
[TBL] [Abstract][Full Text] [Related]
19. Inhaled corticosteroids and hip fracture: a population-based case-control study.
Hubbard RB; Smith CJ; Smeeth L; Harrison TW; Tattersfield AE
Am J Respir Crit Care Med; 2002 Dec; 166(12 Pt 1):1563-6. PubMed ID: 12406825
[TBL] [Abstract][Full Text] [Related]
20. Levothyroxine dose and risk of atrial fibrillation: A nested case-control study.
Gong IY; Atzema CL; Lega IC; Austin PC; Na Y; Rochon PA; Lipscombe LL
Am Heart J; 2021 Feb; 232():47-56. PubMed ID: 33022231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
